EQ: Equillium, Inc. Stock

by  •  • Comments Off on EQ: Equillium, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 63.81
Enterprise Value ($M) 40.98
Book Value ($M) 22.57
Book Value / Share 0.64
Price / Book 2.83
NCAV ($M) 21.39
NCAV / Share 0.61
Price / NCAV 2.98

Profitability (mra)
Return on Invested Capital (ROIC) -0.56
Return on Assets (ROA) -0.19
Return on Equity (ROE) -0.46

Liquidity (mrq)
Quick Ratio 1.79
Current Ratio 1.79

Balance Sheet (mrq) ($M)
Current Assets 49.35
Assets 50.53
Liabilities 27.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 36.08
Operating Income -14.52
Net Income -13.34
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -21.78
Cash from Investing -4.76
Cash from Financing -9.23

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-19 13G Takeda Pharmaceutical Co Ltd 5.20

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 12,908 27,762 46.50
2024-04-25 46,352 19,224 241.12
2024-04-24 10,788 25,194 42.82
2024-04-23 21,341 25,499 83.69
2024-04-22 10,703 19,560 54.72

(click for more detail)

Similar Companies
ENTX – Entera Bio Ltd. ENVB – Enveric Biosciences, Inc.
EPIX – ESSA Pharma Inc. ERNA – Eterna Therapeutics Inc.
ESLA – Estrella Immunopharma, Inc.


Financial data and stock pages provided by
Fintel.io